Skip to content

GEMOPHARM

Technology
Team
News
Contacts

Team

Nail Edikhanov

Yuri Seregin

News

Primer Capital has invested in the development of a Multiple Myeloma drug candidate by GemoPharm LLC 24.11.2017

WordPress.com.

Post to

Cancel